Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Claudin-1, A Double-Edged Sword in Cancer.

Bhat AA, Syed N, Therachiyil L, Nisar S, Hashem S, Macha MA, Yadav SK, Krishnankutty R, Muralitharan S, Al-Naemi H, Bagga P, Reddy R, Dhawan P, Akobeng A, Uddin S, Frenneaux MP, El-Rifai W, Haris M.

Int J Mol Sci. 2020 Jan 15;21(2). pii: E569. doi: 10.3390/ijms21020569. Review.

2.

Anticancer Activity of Camel Milk via Induction of Autophagic Death in Human Colorectal and Breast Cancer Cells

Krishnankutty R, Iskandarani A, Therachiyil L, Uddin S, Azizi F, Kulinski M, Bhat AA, Mohammad RM.

Asian Pac J Cancer Prev. 2018 Dec 25;19(12):3501-3509.

3.

Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report.

Merhi M, Raza A, Inchakalody VP, Nashwan AJJ, Allahverdi N, Krishnankutty R, Uddin S, Zar Gul AR, Al Homsi MU, Dermime S.

Front Immunol. 2018 Jul 30;9:1769. doi: 10.3389/fimmu.2018.01769. eCollection 2018.

4.

Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells.

Prabhu KS, Siveen KS, Kuttikrishnan S, Iskandarani A, Tsakou M, Achkar IW, Therachiyil L, Krishnankutty R, Parray A, Kulinski M, Merhi M, Dermime S, Mohammad RM, Uddin S.

PLoS One. 2017 Jul 13;12(7):e0180895. doi: 10.1371/journal.pone.0180895. eCollection 2017.

5.

Multiple DNA Interactions Contribute to the Initiation of Telomerase Elongation.

Karademir Andersson A, Gustafsson C, Krishnankutty R, Cohn M.

J Mol Biol. 2017 Jul 7;429(14):2109-2123. doi: 10.1016/j.jmb.2017.04.023. Epub 2017 May 12.

PMID:
28506636
6.

Potential therapeutic targets of Guggulsterone in cancer.

Bhat AA, Prabhu KS, Kuttikrishnan S, Krishnankutty R, Babu J, Mohammad RM, Uddin S.

Nutr Metab (Lond). 2017 Feb 28;14:23. doi: 10.1186/s12986-017-0180-8. eCollection 2017. Review.

7.

Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and Challenges.

Siveen KS, Prabhu K, Krishnankutty R, Kuttikrishnan S, Tsakou M, Alali FQ, Dermime S, Mohammad RM, Uddin S.

Curr Vasc Pharmacol. 2017;15(4):339-351. doi: 10.2174/1570161115666170105124038. Review.

PMID:
28056756
8.

Therapeutic Potential of Resveratrol in Lymphoid Malignancies.

Khan OS, Bhat AA, Krishnankutty R, Mohammad RM, Uddin S.

Nutr Cancer. 2016;68(3):365-73. doi: 10.1080/01635581.2016.1152386. Epub 2016 Mar 30. Review.

PMID:
27028800
9.

Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cells.

Iskandarani A, Bhat AA, Siveen KS, Prabhu KS, Kuttikrishnan S, Khan MA, Krishnankutty R, Kulinski M, Nasr RR, Mohammad RM, Uddin S.

J Transl Med. 2016 Mar 9;14:69. doi: 10.1186/s12967-016-0823-y.

10.

Involvement of F-BOX proteins in progression and development of human malignancies.

Uddin S, Bhat AA, Krishnankutty R, Mir F, Kulinski M, Mohammad RM.

Semin Cancer Biol. 2016 Feb;36:18-32. doi: 10.1016/j.semcancer.2015.09.008. Epub 2015 Sep 26. Review.

PMID:
26410033
11.

Adaptation of a commonly used, chemically defined medium for human embryonic stem cells to stable isotope labeling with amino acids in cell culture.

Liberski AR, Al-Noubi MN, Rahman ZH, Halabi NM, Dib SS, Al-Mismar R, Billing AM, Krishnankutty R, Ahmad FS, Raynaud CM, Rafii A, Engholm-Keller K, Graumann J.

J Proteome Res. 2013 Jul 5;12(7):3233-45. doi: 10.1021/pr400099j. Epub 2013 Jun 25.

Supplemental Content

Loading ...
Support Center